Medical Devices

Analogic receives 510(k) U.S. FDA clearance for wide-beam fetal ultrasound transducer

Published in Medical Letter on the CDC and FDA, April 26th, 2006

Analogic Corp. (ALOG) announced that the U.S. Food & Drug Administration (FDA) has given market clearance for a wide-beam fetal ultrasound transducer designed for use with the recently released Fetalgard Lite - NIBP (Non-Invasive Blood Pressure) fetal monitor and with the Fetalgard Lite, both of which are members of Analogic's growing Lifegard family of patient and fetal monitors.

The single-crystal, wide-beam fetal ultrasound transducer is designed to match the current performance levels of the multi-crystal transducers in the marketplace today. Unlike older, multi-crystal designs, the new transducer has a smooth beam pattern with no nulls, producing a smooth,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-04-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry